CELL-BASED THERAPY

CELL-BASED THERAPY

“Recent advances in cellular and molecular biology have increased our understanding of the pathophysiological mechanisms underlying retinal degenerative diseases and consequently enabled expansion of translational research. Therefore, it seemed appropriate to develop a text exploring applications of stem cell therapy to the treatment of these major causes of blindness,” said Dr Casaroli-Marano, professor and researcher, Department of Surgery and Surgical Specializations (School of Medicine), University of Barcelona, Spain.

Dr Zarbin noted that with the entry of cell-based therapy for retinal degenerative diseases into human studies and as the numbers of those trials are growing, various groups of individuals will have an interest in learning more about this topic.

“This book provides a comprehensive, scholarly and practical resource for a broad audience of readers,” said Dr Zarbin, the Alfonse Cinotti MD/Lions Eye research professor and chair, Institute of Ophthalmology & Visual Science, Rutgers-New Jersey Medical School, Newark, NJ.

 

Referenced chapters

The book features 15 referenced chapters that are written by 44 contributors who represent leading experts in their fields. “Potential readers only need to read the preface of the book to determine whether or not it will be helpful to them,” Dr Zarbin said. “Then, with its list of contributors and the references at the end of each chapter, the book provides an excellent starting place for identifying personal contacts and material for further reading for anyone who wants to develop a more
mature understanding of a particular topic.”

 

Marco A Zarbin: zarbin@earthlink.net

Ricardo P Casaroli-Marano: rcasaroli@ub.edu

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...